Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
Clarity Pharmaceuticals Ltd. (CU6) Share Price & Analysis
5 Followers
CU6 Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.59 - AU$1.31
Previous CloseAU$1.06
Volume30.72K
Average Volume (3M)344.04K
Market Cap
AU$277.57M
Enterprise ValueAU$185.23M
Total Cash (Recent Filing)AU$92.34M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-11.2
Beta1.23
Next Earnings
Feb 27, 2024EPS Estimate
-AU$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume344,036
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.63Price Target Upside51.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
CU6 FAQ
What was Clarity Pharmaceuticals Ltd.’s price range in the past 12 months?
Clarity Pharmaceuticals Ltd. lowest share price was AU$0.59 and its highest was AU$1.31 in the past 12 months.
What is Clarity Pharmaceuticals Ltd.’s market cap?
Currently, no data Available
When is Clarity Pharmaceuticals Ltd.’s upcoming earnings report date?
Clarity Pharmaceuticals Ltd.’s upcoming earnings report date is Feb 27, 2024 which is in 131 days.
How were Clarity Pharmaceuticals Ltd.’s earnings last quarter?
Clarity Pharmaceuticals Ltd. released its earnings results on Aug 24, 2023. The company reported -AU$0.052 earnings per share for the quarter, missing the consensus estimate of -AU$0.042 by -AU$0.01.
Is Clarity Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Clarity Pharmaceuticals Ltd.’s price is currently Undervalued.
Does Clarity Pharmaceuticals Ltd. pay dividends?
Clarity Pharmaceuticals Ltd. does not currently pay dividends.
What is Clarity Pharmaceuticals Ltd.’s EPS estimate?
Clarity Pharmaceuticals Ltd.’s EPS estimate is -AU$0.06.
How many shares outstanding does Clarity Pharmaceuticals Ltd. have?
Clarity Pharmaceuticals Ltd. has 261,859,220 shares outstanding.
What happened to Clarity Pharmaceuticals Ltd.’s price movement after its last earnings report?
Clarity Pharmaceuticals Ltd. reported an EPS of -AU$0.052 in its last earnings report, missing expectations of -AU$0.042. Following the earnings report the stock price went up 1.961%.
Which hedge fund is a major shareholder of Clarity Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:CU6
---
Clarity Pharmaceuticals Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$1.63 (51.63% Upside)
AU$1.63 (51.63% Upside)
Blogger Sentiment
Bullish
AU:CU6 Sentiment 100%
Sector Average 69%
Sector Average 69%
Technicals
SMA
Positive
20 days / 200 days
Momentum
79.66%
12-Months-Change
Fundamentals
Return on Equity
-30.48%
Trailing 12-Months
Asset Growth
-22.97%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.
---
Advanced Human Imaging Ltd.
―
Alcidion Group Limited
―
Rhythm Biosciences Ltd.
―
Apiam Animal Health Ltd.
―
---